Data as of .
ARKG vs FBT: which is really different?
ARKG and FBT hold 10% of their weight in the same names, and ARKG returned more over the year.
ETFIQ Off-Index Score: FBT scores higher
How much of it is not the index it is sold as an alternative to?
A percentile among the 379 thematic ETFs with a holdings filing. It is a position in a set, not a rating, and neither end of it is a recommendation. All thematic ETFs ranked by it · How it is computed
10% of the two portfolios are the same securities at the same weight.
What they hold in common
By the books each fund has filed, ARKG and FBT hold 10% of their money in the same securities at the same weight.
| Holding | ARKG | FBT |
|---|---|---|
| NATERA INC | 4.25% | 4.24% |
| ILLUMINA INC | 4.13% | 3.90% |
| VERACYTE INC | 1.76% | 2.16% |
| Only in ARKG | Only in FBT |
|---|---|
| TWIST BIOSCIENCE CORP 9.63% | Halozyme Therapeutics, Inc. 4.57% |
| 10X GENOMICS INC-CLASS A 9.39% | NeoGenomics, Inc. 4.37% |
| TEMPUS AI INC-CL A 8.92% | Repligen Corporation 3.80% |
| CRISPR THERAPEUTICS AG 5.63% | Corcept Therapeutics Inc. 3.72% |
| PERSONALIS INC 5.16% | Genmab A/S (ADR) 3.71% |
| GUARDANT HEALTH INC 4.87% | Regeneron Pharmaceuticals, Inc. 3.66% |
| ABSCI CORP 4.76% | BeOne Medicines Ltd. (ADR) 3.64% |
| CAREDX INC 3.78% | Gilead Sciences, Inc. 3.58% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Sep 18, 2026 and Sep 21, 2026.
Performance, window by window
| Window | Total return | vs the S&P 500 | vs the Nasdaq-100 | |||
|---|---|---|---|---|---|---|
| ARKG | FBT | ARKG | FBT | ARKG | FBT | |
| 3 months | +40.1% | +17.2% | +37.9 pts | +14.9 pts | +42.6 pts | +19.6 pts |
| 6 months | +98.2% | +40.6% | +80.2 pts | +22.6 pts | +74.0 pts | +16.4 pts |
| 1 year | +87.1% | +48.9% | +70.6 pts | +32.3 pts | +65.4 pts | +27.1 pts |
| 3 years | +74.8% | +80.7% | −3.6 pts | +2.3 pts | −23.4 pts | −17.5 pts |
| Since launch | +174.6% | +848.2% | −186.8 pts | +44.6 pts | −504.0 pts | −842.1 pts |
| ARKG ARK Genomic Revolution ETF Holds 33 stocks in genomics and gene editing, 4% of its weight in S&P 500 companies | FBT First Trust NYSE Arca Biotechnology Index Fund Holds 31 stocks in biotech, 24% of its weight in S&P 500 companies | |
|---|---|---|
| Issuer | ARK | First Trust |
| Theme | Genomics and gene editing | Biotech |
| In the S&P 500 | 3.5% | 23.6% |
| Active share vs the S&P 500 | 98.5% | 99.1% |
| In the Nasdaq-100 | 0.0% | 16.2% |
| Holdings | 33 | 31 |
| Top ten, share of the fund | 60.4% | 39.2% |
| Expense ratio | 0.75% | 0.55% |
| Fee for the differing part | 0.76% | 0.55% |
| Total return, 1 year | +87.1% | +48.9% |
| vs the S&P 500 | +70.6 pts | +32.3 pts |
| vs the Nasdaq-100 | +65.4 pts | +27.1 pts |
| Below its high | −53.8% | −2.1% |
| Net assets | $2.2bn | $2.9bn |
ARKG in plain words
By weight, 4% of ARKG's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 60% of the fund across 33 positions, as published by its issuer for Sep 21, 2026. Over the year to Sep 18, 2026 the fund returned +87.1% with distributions reinvested against +16.6% for the S&P 500, so a holder was ahead by 70.6 pts. It sits 53.8% below its all-time high of Jan 20, 2021.
FBT in plain words
By weight, 24% of FBT's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 39% of the fund across 31 positions, as published by its issuer for Sep 18, 2026. Over the year to Sep 18, 2026 the fund returned +48.9% with distributions reinvested against +16.6% for the S&P 500, so a holder was ahead by 32.3 pts.
Questions people ask
- Do ARKG and FBT hold the same stocks?
- By their latest filings, 10% of their books are the same securities at the same weight, which is mostly different names. Overlap is the sum of the smaller weight of every security they share.
- Which is more different from the S&P 500, ARKG or FBT?
- ARKG has 4% of its weight in S&P 500 names and FBT has 24%, so FBT differs more from the index.
- Which is cheaper, ARKG or FBT?
- ARKG charges 0.75% a year and FBT charges 0.55%, so FBT is cheaper. Fees come from each fund's prospectus.
Other comparisons
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, ARKG against FBT, data as of Sep 18, 2026. https://etfiq.com/compare/themes/arkg-vs-fbt Free to use with attribution; the underlying files are at Open data.